Skip to main content
. 2019 Aug 21;8(17):e013114. doi: 10.1161/JAHA.119.013114

Table 4.

KCCQ Scores by Diabetic Status

Quality‐of‐Life Domains P interaction (Diabetes Mellitus×HF Group) HFrEF HFpEF
Diabetes Mellitus No Diabetes Mellitus P Value Diabetes Mellitus No Diabetes Mellitus P Value
Physical limitation score 0.002 66.5 (0.6) 68.8 (0.5) 0.007 70.6 (1.2) 77.8 (1.1) <0.001
Symptom stability score 0.048 63.1 (0.7) 63.6 (0.6) 0.597 56.4 (1.4) 59.3 (1.3) 0.139
Symptom frequency score 0.141 66.6 (0.7) 69.4 (0.5) 0.001 68.0 (1.5) 73.0 (1.3) 0.014
Symptom burden score 0.054 70.1 (0.6) 72.2 (0.5) 0.015 75.1 (1.2) 80.0 (1.1) 0.004
Total symptom score 0.081 68.3 (0.6) 70.8 (0.5) 0.003 71.6 (1.3) 76.5 (1.1) 0.005
Self‐efficacy score 0.050 64.3 (0.7) 64.8 (0.5) 0.584 65.4 (1.4) 68.4 (1.3) 0.124
Quality‐of‐life score 0.001 55.8 (0.6) 56.7 (0.5) 0.259 64.4 (1.2) 69.8 (1.1) 0.001
Social limitation score 0.001 59.8 (0.8) 63.1 (0.7) 0.003 70.2 (1.6) 79.5 (1.5) <0.001
Overall summary score 0.001 62.8 (0.6) 65.0 (0.4) 0.004 69.1 (1.1) 75.8 (1.0) <0.001
Clinical summary score 0.006 67.5 (0.6) 69.9 (0.4) 0.001 70.9 (1.1) 77.0 (1.0) <0.001

Data are presented as adjusted mean (SE). Adjusted for age, sex, ethnicity, regional income, hypertension, systolic blood pressure, heart rate, ejection fraction, obstructive pulmonary disease, atrial fibrillation, peripheral arterial disease, coronary artery disease, educational status, angiotensin‐converting enzyme inhibitors/angiotensin II receptor blockers, β blockers, and diuretics. HF indicates heart failure; HFpEF, HF with preserved ejection fraction; HFrEF, HF with reduced ejection fraction; KCCQ, Kansas City Cardiomyopathy Questionnaire.